|
|
Prepublished online as a Blood First Edition Paper on April 10, 2003; DOI 10.1182/blood-2002-07-2015.

Submitted July 8, 2002
Accepted April 2, 2003
Telomerase levels control the life span of human T lymphocytes
Alexander Roeth, Hans Yssel, Jerome Pene, Elizabeth A Chavez, Mike Schertzer, Peter M Lansdorp, Hergen Spits*, and Rosalie M Luiten
Terry Fox Laboratory, British Columbia Cancer Agency and University of British Columbia, Vancouver, BC, Canada
INSERM U454, Montpellier, France
Immunology, The Netherlands Cancer Institute / Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands; Cell Biology & Histology AMC, University of Amsterdam, Amsterdam, The Netherlands
Immunology, The Netherlands Cancer Institute / Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands
* Corresponding author; email: hergen.spits{at}amc.uva.nl.
The loss of telomeric DNA with each cell division contributes to the limited replicative life span of human T lymphocytes. Although telomerase is transiently expressed in T lymphocytes upon activation, it is insufficient to confer immortality. We have shown previously that immortalization of human CD8+ T lymphocytes can be achieved by ectopic expression of the hTERT gene, which encodes for the catalytic component of the telomerase complex. To study the role of endogenous hTERT in the life span of human T cells, we blocked endogenous hTERT expression by ectopic expression of dominant-negative (DN) hTERT. Cells expressing DN-hTERT had a decreased life span and showed cytogenetic abnormalities, including chromosome ends without detectable telomeric DNA as well as chromosome fusions. These results indicate that while endogenous hTERT cannot prevent overall telomere shortening, it has a major influence on the longevity of human T cells. Furthermore, we show that upregulation of hTERT in T cells upon activation decreases over time in culture. Long-term cultured T cells also show a decreased expression of c-myc upon activation, resulting in less c-myc-induced transcription of hTERT. Moreover, memory T cells, which have expanded in vivo upon antigen encounter, expressed a lower level of hTERT upon activation than naive cells from the same donor. The observed inverse correlation between telomerase levels and replicative history suggests that telomerase levels in T cells are limiting and increasingly insufficient to sustain their proliferation.

CiteULike Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
H. Fujii, L. Shao, I. Colmegna, J. J. Goronzy, and C. M. Weyand
Telomerase insufficiency in rheumatoid arthritis
PNAS,
March 17, 2009;
106(11):
4360 - 4365.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. L. Putnam, T. M. Brusko, M. R. Lee, W. Liu, G. L. Szot, T. Ghosh, M. A. Atkinson, and J. A. Bluestone
Expansion of Human Regulatory T-Cells From Patients With Type 1 Diabetes
Diabetes,
March 1, 2009;
58(3):
652 - 662.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. R. Fauce, B. D. Jamieson, A. C. Chin, R. T. Mitsuyasu, S. T. Parish, H. L. Ng, C. M. Ramirez Kitchen, O. O. Yang, C. B. Harley, and R. B. Effros
Telomerase-Based Pharmacologic Enhancement of Antiviral Function of Human CD8+ T Lymphocytes
J. Immunol.,
November 15, 2008;
181(10):
7400 - 7406.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Lichterfeld, D. Mou, T. D. H. Cung, K. L. Williams, M. T. Waring, J. Huang, F. Pereyra, A. Trocha, G. J. Freeman, E. S. Rosenberg, et al.
Telomerase activity of HIV-1-specific CD8+ T cells: constitutive up-regulation in controllers and selective increase by blockade of PD ligand 1 in progressors
Blood,
November 1, 2008;
112(9):
3679 - 3687.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Yang, J. An, and N.-p. Weng
Telomerase Is Involved in IL-7-Mediated Differential Survival of Naive and Memory CD4+ T Cells
J. Immunol.,
March 15, 2008;
180(6):
3775 - 3781.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. D. Kilpatrick, T. Rickabaugh, L. E. Hultin, P. Hultin, M. A. Hausner, R. Detels, J. Phair, and B. D. Jamieson
Homeostasis of the Naive CD4+ T Cell Compartment during Aging
J. Immunol.,
February 1, 2008;
180(3):
1499 - 1507.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. K. Damjanovic, Y. Yang, R. Glaser, J. K. Kiecolt-Glaser, H. Nguyen, B. Laskowski, Y. Zou, D. Q. Beversdorf, and N.-p. Weng
Accelerated Telomere Erosion Is Associated with a Declining Immune Function of Caregivers of Alzheimer's Disease Patients
J. Immunol.,
September 15, 2007;
179(6):
4249 - 4254.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Zhou, X. Shen, J. Huang, R. J. Hodes, S. A. Rosenberg, and P. F. Robbins
Telomere Length of Transferred Lymphocytes Correlates with In Vivo Persistence and Tumor Regression in Melanoma Patients Receiving Cell Transfer Therapy
J. Immunol.,
November 15, 2005;
175(10):
7046 - 7052.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Nordfjall, A. Larefalk, P. Lindgren, D. Holmberg, and G. Roos
Telomere length and heredity: Indications of paternal inheritance
PNAS,
November 8, 2005;
102(45):
16374 - 16378.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Ly, M. Schertzer, W. Jastaniah, J. Davis, S. L. Yong, Q. Ouyang, E. H. Blackburn, T. G. Parslow, and P. M. Lansdorp
Identification and functional characterization of 2 variant alleles of the telomerase RNA template gene (TERC) in a patient with dyskeratosis congenita
Blood,
August 15, 2005;
106(4):
1246 - 1252.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Roth, G. M. Baerlocher, M. Schertzer, E. Chavez, U. Duhrsen, and P. M. Lansdorp
Telomere loss, senescence, and genetic instability in CD4+ T lymphocytes overexpressing hTERT
Blood,
July 1, 2005;
106(1):
43 - 50.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Li, W. Zhi, P. Wareski, and N.-p. Weng
IL-15 Activates Telomerase and Minimizes Telomere Loss and May Preserve the Replicative Life Span of Memory CD8+ T Cells In Vitro
J. Immunol.,
April 1, 2005;
174(7):
4019 - 4024.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. Dalerba, C. Guiducci, P. L. Poliani, I. Cifola, M. Parenza, M. Frattini, G. Gallino, I. Carnevali, I. Di Giulio, S. Andreola, et al.
Reconstitution of Human Telomerase Reverse Transcriptase Expression Rescues Colorectal Carcinoma Cells from In vitro Senescence: Evidence against Immortality as a Constitutive Trait of Tumor Cells
Cancer Res.,
March 15, 2005;
65(6):
2321 - 2329.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Knudson, S. Kulkarni, Z. K. Ballas, M. Bessler, and F. Goldman
Association of immune abnormalities with telomere shortening in autosomal-dominant dyskeratosis congenita
Blood,
January 15, 2005;
105(2):
682 - 688.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Gimeno, K. Weijer, A. Voordouw, C. H. Uittenbogaart, N. Legrand, N. L. Alves, E. Wijnands, B. Blom, and H. Spits
Monitoring the effect of gene silencing by RNA interference in human CD34+ cells injected into newborn RAG2-/- {gamma}c-/- mice: functional inactivation of p53 in developing T cells
Blood,
December 15, 2004;
104(13):
3886 - 3893.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
W Klapper, F Moosig, A Sotnikova, W Qian, J O Schroder, and R Parwaresch
Telomerase activity in B and T lymphocytes of patients with systemic lupus erythematosus
Ann Rheum Dis,
December 1, 2004;
63(12):
1681 - 1683.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Dagarag, T. Evazyan, N. Rao, and R. B. Effros
Genetic Manipulation of Telomerase in HIV-Specific CD8+ T Cells: Enhanced Antiviral Functions Accompany the Increased Proliferative Potential and Telomere Length Stabilization
J. Immunol.,
November 15, 2004;
173(10):
6303 - 6311.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. Erdmann, Y. Liu, and L. Harrington
Distinct dosage requirements for the maintenance of long and short telomeres in mTert heterozygous mice
PNAS,
April 20, 2004;
101(16):
6080 - 6085.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. C. V. Verra, A. Jorritsma, K. Weijer, J. J. Ruizendaal, A. Voordouw, P. Weder, E. Hooijberg, T. N. M. Schumacher, J. B. A. G. Haanen, H. Spits, et al.
Human Telomerase Reverse Transcriptase-Transduced Human Cytotoxic T Cells Suppress the Growth of Human Melanoma in Immunodeficient Mice
Cancer Res.,
March 15, 2004;
64(6):
2153 - 2161.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|
|